Download PDF
Thromb Haemost 1966; 15(01/02): 220-230
DOI: 10.1055/s-0038-1649423
Originalarbeiten — Original Articles — Travaux Originaux
Schattauer GmbH

The Plasminogen Content of Thrombi[*]

D Ogston
1   Department of Medicine, University of Aberdeen, Aberdeen, Scotland
,
C. M Ogston
1   Department of Medicine, University of Aberdeen, Aberdeen, Scotland
,
H. W Fullerton
1   Department of Medicine, University of Aberdeen, Aberdeen, Scotland
› Author Affiliations
Further Information

Publication History

Publication Date:
27 June 2018 (online)

    Permissions and Reprints

Summary

1. The plasminogen content of serum and plasma does not differ. The serum remaining after the production of an in vitro artificial thrombus has a plasminogen content similar to the original plasma. Direct measurement of the plasminogen content of artificial thrombi confirms that little plasminogen is adsorbed onto fibrin during the process of clotting.

2. The lysis of pre-formed artificial thrombi by urokinase is substantially increased in the presence of plasma. This is not due to free plasmin in the medium surrounding the thrombus.

3. Partially purified plasminogen is adsorbed onto artificial thrombi endowing them with the capacity to lyse on the addition of urokinase. In contrast plasminogen from plasma or serum is not adsorbed onto thrombi.

4. We suggest that the lysis of a thrombus results from diffusion of circulating plasminogen into the thrombus and its interaction with activator on the surface of the fibrin fibrils with consequent plasmin formation.

* This investigation was supported by a grant fron1 the Tobacco Research Council of Great Britain on the recommendation of the British Heart Foundation.


 

  • References

  • 1 Sherry S, Fletcher A. P, Alkjaersig N. Fibrinolysis and fibrinolytic activity in man. Physiol Rev 39: 343 1959;
    CrossrefPubMedGoogle Scholar
  • 2 Sawyer W. D, Alkjaersig N, Fletcher A. P, Sherry S. Thrombolytic therapy. Basic and therapeutic considerations. A. M. A. Arch. intern. Med 107: 274 1961;
    CrossrefPubMedGoogle Scholar
  • 3 Fantl P. Plasminogen activity of plasma and serum. Science 135: 787 1962;
    CrossrefPubMedGoogle Scholar
  • 4 Dudok de Wit C. The role of plasminogen in fibrinolysis. Vox Sang (Basel) 07: 526 1962;
    CrossrefPubMedGoogle Scholar
  • 5 Ambrus J. L, Markus G. Plasmin-antiplasmin complex as reservoir of fibrinolytic enzyme. Amer. J. Physiol 199: 491 1960;
    PubMedGoogle Scholar
  • 6 Chandler A. B. In vitro thrombotic coagulation of blood; a method for producing a thrombus. Lab. Invest 07: 110 1958;
    PubMedGoogle Scholar
  • 7 Poole J. C. A study of artificial thrombi produced by a modification of Chandler’s method. Quart. J. exp. Physiol 44: 372 1959;
    PubMedGoogle Scholar
  • 8 Ploug J, Kjeldgaard N. O. Urokinase, an activator of plasminogen from human urine. Biochim. biophys. Acta (Amst) 24: 278 1957;
    CrossrefPubMedGoogle Scholar
  • 9 Remmert L. F, Cohen P. P. Partial purification and properties of a proteolytic enzyme of human serum. J. biol. Chem 181: 431 1949;
    PubMedGoogle Scholar
  • 10 Alkjaersig N, Fletcher A. P, Sherry S. The mechanism of clot dissolution by plasmin. J. clin. Invest 38: 1086 1959;
    CrossrefPubMedGoogle Scholar